Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
STRO · NASDAQ · Biological Products, (No Diagnostic Substances)
$8.60−0.12 (−1.38%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Sutro Biopharma (STRO) · oqro.io/stocks/STRO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Nov 5, 2026 · Filed Nov 9, 2026
Coastlands Capital LP now owns 5.1% of STRO as a passive investorSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Perceptive Advisors LLC disclosed an increased position in STRO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Eventide Asset Management, LLC disclosed a reduced position in STRO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed a reduced position in STRO for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 29, 2026
Perceptive Advisors LLC disclosed a new position in STRO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed a new position in STRO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Eventide Asset Management, LLC disclosed a new position in STRO for Q1 2026SourceInsider trade · Traded Oct 15, 2025 · Filed Oct 16, 2025
CEO purchased ~$10K of STRO shares in the open marketSourceInsider trade · Traded Oct 15, 2025 · Filed Oct 16, 2025
Officer purchased ~$14K of STRO shares in the open marketSourceInsider trade · Traded Oct 15, 2025 · Filed Oct 16, 2025
Director purchased ~$40K of STRO shares in the open marketSourceInsider trade · Traded Oct 15, 2025 · Filed Oct 16, 2025
CFO purchased ~$16K of STRO shares in the open marketSource